| 000 | 01802 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517222546.0 | ||
| 264 | 0 | _c20190509 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1879-355X | ||
| 024 | 7 |
_a10.1016/j.ijrobp.2018.04.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBryant, Alex K | |
| 245 | 0 | 0 |
_aDefinitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _c08 2018 |
||
| 300 |
_a1188-1193 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aHospitals, Veterans |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aLymph Nodes _xpathology |
| 650 | 0 | 4 | _aLymphatic Metastasis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xmortality |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKader, Andrew K | |
| 700 | 1 | _aMcKay, Rana R | |
| 700 | 1 | _aEinck, John P | |
| 700 | 1 | _aMell, Loren K | |
| 700 | 1 | _aMundt, Arno J | |
| 700 | 1 | _aKane, Christopher J | |
| 700 | 1 | _aEfstathiou, Jason A | |
| 700 | 1 | _aMurphy, James D | |
| 700 | 1 | _aRose, Brent S | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 101 _gno. 5 _gp. 1188-1193 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijrobp.2018.04.023 _zAvailable from publisher's website |
| 999 |
_c28519101 _d28519101 |
||